TRESEA JETER: Open Payments
NPI 1225248602 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,096 in 202 payments from 13 companies in 2025. Trend: 2023 $1,841 · 2024 $2,385 · 2025 $3,096
Food & beverage: $3,012Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $708 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $467 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $321 |
| Janssen Biotech, Inc. | 19 | $302 |
| Madrigal Pharmaceuticals | 14 | $285 |
| Ardelyx, Inc. | 12 | $201 |
| Regeneron Healthcare Solutions, Inc. | 12 | $181 |
| Phathom Pharmaceuticals, Inc. | 22 | $171 |
| Aimmune Therapeutics, Inc. | 11 | $160 |
| QOL Medical, LLC | 5 | $139 |
Products named: ENTYVIO, XIFAXAN, TREMFYA, REZDIFFRA, RINVOQ, IBSRELA, DUPIXENT, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
